ロード中...
Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgaris
A novel administration strategy of immunoglobulin treatment is represented by injection of recombinant human hyaluronidase (rHUPH20) with subcutaneous immunoglobulins. The use of facilitated subcutaneous immunoglobulin treatment (fSCIG) for the treatment of autoimmune conditions is yet to be investi...
保存先:
| 出版年: | BMJ Case Rep |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5976112/ https://ncbi.nlm.nih.gov/pubmed/29848521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-223302 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|